BUSINESS INFORMATION REPORT

 

1. Summary Information         

 

 

Country

INDIA

Company Name

ZUVIUS LIFESCIENCES PRIVATE LIMITED

Principal Name 1

MR. NIMISH GUABDAS THAKKER

Status

MODERATE

Principal Name 2

MR. SHAILESH THIMMAPPA SHETTY

 

 

Registration #

11-155998

Street Address

301, B WING, 3RD FLOOR, KANARA BUSINESS CENTER, LAXMI NAGAR, OPPOSITE GHATKOPAR ANDHERI LINK ROAD, GHATKOPAR (EAST),  MUMBAI – 400 075, MAHARASHTRA

Established Date

13.09.2005

SIC Code

--

Telephone#

91-22-67653561

Business Style 1

MANUFACTURING

Fax #

91-22-25006141

Business Style 2

MARKETING

Homepage

www.zuviuslifesciences.in

Product Name 1

PHARMACEUTICAL PRODUCTS

# of employees

26 (APPROXIMATELY)

Product Name 2

--

Paid up capital

RS.100,000/- 

Product Name 3

--

Shareholders

DIRECTORS OR RELATIVES OF DIRECTORS – 100%

Banking

ING VYSYA BANK LIMITED

Public Limited Corp.

NO

Business Period

6 YEARS

IPO

NO

International Ins.

--

Public Enterprise

NO

Rating

B (26)

Related Company

Relation

Country

Company Name

CEO

--

--

--

--

Note

--

 

2. Summary Financial Statement

Balance Sheet as of

31.03.2010

(Unit: Indian Rs.)

Assets

Liabilities

Current Assets

31,116,000

Current Liabilities

31,561,000

Inventories

8,925,000

Long-term Liabilities

5,714,000

Fixed Assets

52,000

Other Liabilities

759,000

Deferred Assets

14,000

Total Liabilities

38,034,000

Invest& other Assets

0,000

Retained Earnings

(428,000)

 

 

Net Worth

2,073,000

Total Assets

40,107,000

Total Liab. & Equity

40,107,000

 Total Assets

(Previous Year)

15,769,000

 

 

P/L Statement as of

31.03.2010

(Unit: Indian Rs.)

Total Income

42,260,000

Net Profit

555,000

Total Income (Previous yr)

52,381,000

Net Profit(Prev.yr)

715,000

MIRA INFORM REPORT

 

 

Report Date :

25.08.2011

 

IDENTIFICATION DETAILS

 

Name :

ZUVIUS LIFESCIENCES PRIVATE LIMITED

 

 

Registered Office :

301, B Wing, 3rd Floor, Kanara Business Center, Laxmi Nagar, Opposite Ghatkopar Andheri Link Road, Ghatkopar (East),  Mumbai – 400 075, Maharashtra

 

 

Country :

India

 

 

Financials (as on) :

31.03.2010

 

 

Date of Incorporation :

13.09.2005

 

 

Com. Reg. No.:

11-155998

 

 

Capital Investment / Paid-up Capital :

Rs.0.100 million

 

 

CIN No.:

[Company Identification No.]

U24230MH2005PTC155998

 

 

TAN No.:

[Tax Deduction & Collection Account No.]

MUMZ01317B

 

 

Legal Form :

Private Limited Liability Company

 

 

Line of Business :

Manufacturing and Marketing of Pharmaceutical Products.

 

 

No. of Employees :

26 (Approximately)

 

 

RATING & COMMENTS

 

MIRA’s Rating :

B (26)

 

RATING

STATUS

 

PROPOSED CREDIT LINE

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

Small

 

Maximum Credit Limit :

USD 8000

 

 

Status :

Moderate

 

 

Payment Behaviour :

Slow

 

 

Litigation :

Clear

 

 

Comments :

Subject is an established company having moderate track. There appears some accumulated losses recorded by the company. However trade relations are reported as fair. Business is active. Payments are reported to be slow.

 

The company can be considered for business dealings with some caution.

 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

 

ECGC Country Risk Classification List – April 1, 2010

 

Country Name

Previous Rating

(31.12.2009)

Current Rating

(01.04.2010)

India

A1

A1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 

 

INFORMATION PARTED BY

 

Name :

Mr. Nimish Guabdas Thakker

Designation :

Whole Time Director

Contact No.:

91-9594997991

Date :

23.08.2011

 

 

LOCATIONS

 

Registered/ Corporate Office :

301, B Wing, 3rd Floor, Kanara Business Center, Laxmi Nagar, Opposite Ghatkopar Andheri Link Road, Ghatkopar (East),  Mumbai – 400 075, Maharashtra, India

Tel. No.:

91-22-67653561/ 67653562/ 67653564/ 67653565

Mobile No.: 

91-9594997991 (Mr. Nimish Guabdas Thakker)

Fax No.:

91-22-25006141/ 25006591

E-Mail :

mktg.zuvius@yahoo.co.in

nimish@zuviuslifesciences.in

zuviuslifesciences@yahoo.co.in

General Info: info@zuviuslifesciences.in

CEOCEO@zuviuslifesciences.in

Admin: admin@zuviuslifesciences.in

Marketing: marketing@zuviuslifesciences.in

Website :

http://www.zuviuslifesciences.in

Area :

4000 sq ft

Location :

Owned

 

 

Factory :

B-1, Wagle Industrial Estate, Thane, Maharashtra, India

 

 

DIRECTORS

 

As on 30.09.2010

 

Name :

Mr. Nimish Guabdas Thakker

Designation :

Whole Time Director

Address :

E/12/13, Santoshi Villa, Rajaji Path, Ramnagar, Dombivli (East), Thane District, Thane – 421 201, Maharashtra, India

Date of Birth/Age :

10.09.1975

Date of Appointment :

13.09.2005

DIN No.:

00442166

 

 

Name :

Mr. Shailesh Thimmappa Shetty

Designation :

Whole Time Director

Address :

E/11, Santoshi Villa, Rajaji Path, Ramnagar, Dombivli (East), Thane District, Thane – 421 201, Maharashtra, India

Date of Birth/Age :

31.05.1977

Date of Appointment :

13.09.2005

DIN No.:

00442571

 

 

Name :

Mrs. Alka S. Chavan

Designation :

Whole Time Director

Address :

W-20, Santoshi Villa, Rajaji Path, Ramnagar, Dombivli (East), Thane District, Thane – 421 201, Maharashtra, India

Date of Birth/Age :

08.02.1976

Date of Appointment :

13.09.2005

DIN No.:

01769613

 

 

Name :

Mr. Dipesh Hemraj Pasad

Designation :

Director

Address :

Hem Deep, Plot No.92, Hanuman CHS, Opposite D.N.C. School, Dombivli (East), Thane – 421 201, Maharashtra, India

Date of Birth/Age :

26.03.1971

Date of Appointment :

17.10.2010

DIN No.:

01553811

 

 

Name :

Mrs. Sharda Gulabdas Thakker

Designation :

Whole Time Director

Address :

E/12/13, Santoshi Villa, Rajaji Path, Ramnagar, Dombivli (East), Thane District, Thane – 421 201, Maharashtra, India

Date of Birth/Age :

28.09.1947

Date of Appointment :

13.09.2005

Date of Ceasing :

06.07.2009

DIN No.:

00442370

 

 

MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN

 

As on 30.09.2010

 

Names of Shareholders

 

 

No. of Shares

Nimish Guabdas Thakker

 

21540

Sharda Gulabdas Thakker

 

2500

Shailesh Thimmappa Shetty

 

2490

Alka S. Chavan

 

1190

Santosh Chavan

 

390

Bijal Thakker

 

2400

Nilesh Thakker

 

6000

Harshal Mayush

 

1500

Total

 

38010

 

As on 30.09.2010

 

Equity Share Breakup

 

Percentage of Holding

Category

 

 

Directors or relatives of directors

 

100.00

 

 

BUSINESS DETAILS

 

Line of Business :

Manufacturing and Marketing of Pharmaceutical Products.

 

 

Terms :

 

Selling :

Cash and Credit

 

 

Purchasing :

Cash and Credit 

 

 

GENERAL INFORMATION

 

Customers :

Wholesalers and Retailers

 

 

No. of Employees :

26 (Approximately)

 

 

Bankers :

v      Axis Bank, Dombivali (East), Thane, Maharashtra, India

v      ING Vysya Bank Limited, Unit No.2/3/4, Marathon Max Building, Mulund Goregoan Link Road, Mulund (West), Mumbai – 400 080, Maharashtra, India

v      Corporation Bank, Dombivali (West) Branch

 

 

 

Banking Relations :

--

 

 

Auditors :

 

Name :

H.J. Mehta and Associates

Chartered Accountants 

Address :

Shop No.4, Panchsheel Building, Nath Pai Nagar, Opposite Vidya Bhavan School, Ghatkopar (East), Mumbai – 400 077, Maharashtra, India

Tel. No.:

91-22-32946898/ 25068664

Fax No.:

91-22-25068664

Income-tax PAN of auditor or auditor's firm :

AADFH5290E

 

 

CAPITAL STRUCTURE

 

As on 30.09.2010

 

Authorised Capital :

No. of Shares

Type

Value

Amount

50000

Equity Shares

Rs.10/- each

Rs.0.500 million

 

 

 

 

 

Issued, Subscribed & Paid-up Capital :

No. of Shares

Type

Value

Amount

38010

Equity Shares

Rs.10/- each

Rs.0.380 million

 

 

 

 

 

As on 31.03.2010

 

Authorised Capital :

No. of Shares

Type

Value

Amount

50000

Equity Shares

Rs.10/- each

Rs.0.500 million

 

 

 

 

 

Issued, Subscribed & Paid-up Capital :

No. of Shares

Type

Value

Amount

10000

Equity Shares

Rs.10/- each

Rs.0.100 million

 

 

 

 

 

 


 

FINANCIAL DATA

[all figures are in Rupees Millions]

 

ABRIDGED BALANCE SHEET

 

SOURCES OF FUNDS

 

31.03.2010

31.03.2009

31.03.2008

SHAREHOLDERS FUNDS

 

 

 

1] Share Capital

0.100

0.100

0.100

2] Share Application Money

2.401

2.401

2.596

3] Reserves & Surplus

0.000

0.000

0.000

4] (Accumulated Losses)

(0.428)

(0.983)

(1.644)

NETWORTH

2.073

1.518

1.052

LOAN FUNDS

 

 

 

1] Secured Loans

3.161

5.246

2.669

2] Unsecured Loans

2.553

1.813

0.000

TOTAL BORROWING

5.714

7.059

2.669

DEFERRED TAX LIABILITIES

0.000

0.000

0.000

 

 

 

 

TOTAL

7.787

8.577

3.721

 

 

 

 

APPLICATION OF FUNDS

 

 

 

 

 

 

 

FIXED ASSETS [Net Block]

0.052

0.013

0.016

Capital work-in-progress

0.000

0.000

0.000

 

 

 

 

INVESTMENT

0.000

0.000

0.000

DEFERRED TAX ASSETS

0.014

0.000

0.000

 

 

 

 

CURRENT ASSETS, LOANS & ADVANCES

 

 

 

 

Inventories

8.925
9.337

6.380

 

Sundry Debtors

29.941
4.923

10.421

 

Cash & Bank Balances

0.300
0.058

0.082

 

Other Current Assets

0.000
0.157

0.147

 

Loans & Advances

0.875
1.281

0.989

Total Current Assets

40.041

15.756

18.019

Less : CURRENT LIABILITIES & PROVISIONS

 

 

 

 

Sundry Creditors

30.689
5.414

12.348

 

Other Current Liabilities

0.872
1.208

1.788

 

Provisions

0.759
0.570

0.178

Total Current Liabilities

32.320

7.192

14.314

Net Current Assets

7.721
8.564

3.705

 

 

 

 

MISCELLANEOUS EXPENSES

0.000

0.000

0.000

 

 

 

 

TOTAL

7.787

8.577

3.721

 


PROFIT & LOSS ACCOUNT

 

 

PARTICULARS

31.03.2010

31.03.2009

31.03.2008

 

SALES

 

 

 

 

 

Income

42.260

52.381

47.802

 

 

Other Income

 

 

 

 

 

TOTAL                                    

42.260

52.381

47.802

 

 

 

 

 

 

EXPENSES

 

 

 

 

 

Office Expenses

41.610

51.556

50.709

 

 

Administrative Expenses

 

 

 

 

 

Advertising Expenses

 

 

 

 

 

TOTAL                                    

41.610

51.556

50.709

 

 

 

 

 

 

PROFIT BEFORE TAX

0.650

0.825

0.817

 

 

 

 

 

Less

TAX                                                                 

0.095

0.110

0.080

 

 

 

 

 

 

PROFIT AFTER TAX

0.555

0.715

0.737

 

 

 

 

 

 

Earnings Per Share (Rs.)

5.55

71.50

73.75

 

Particulars

 

 

 

31.03.2011

(Approximately)

Sales Turnover

 

 

60.000

 

 

 

 

Profitability

 

 

2.200

 

The above information has been parted by Mr. Nimish Guabdas Thakker (Whole Time Director).

 

KEY RATIOS

 

PARTICULARS

 

 

31.03.2010

31.03.2009

31.03.2008

PAT / Total Income

(%)

1.31
1.36

1.54

 

 

 
 

 

Return on Total Assets

(PBT/Total Assets}

(%)

1.62
5.23

4.53

 

 

 
 

 

Return on Investment (ROI)

(PBT/Networth)

 

0.31
0.54

0.78

 

 

 
 

 

Debt Equity Ratio

(Total Liability/Networth)

 

18.35
9.39

16.14

 

 

 
 

 

Current Ratio

(Current Asset/Current Liability)

 

1.24
2.19

1.26

 

 

LOCAL AGENCY FURTHER INFORMATION

 

FORM 8:

 

This form is for

Creation of charge

Corporate identity number of the company

U24230MH2005PTC155998

Name of the company

ZUVIUS LIFESCIENCES PRIVATE LIMITED

Address of the registered office or of the principal place of  business in India of the company

301, B Wing, 3rd Floor, Kanara Business Center, Laxmi Nagar, Opposite Ghatkopar Andheri Link Road, Ghatkopar (East),  Mumbai – 400 075, Maharashtra, India

Type of charge

Book Debts

Floating Charge

Particular of charge holder

ING Vysya Bank Limited, Unit No.2/3/4, Marathon Max Building, Mulund Goregoan Link Road, Mulund (West), Mumbai – 400 080, Maharashtra, India

E-Mail: mulund@ingvysyabank.com

Nature of description of the instrument creating or modifying the charge

General Hypothecation Agreement.

Date of instrument Creating the charge

02.01.2009

Amount secured by the charge

Rs.5.000 millions

Brief particulars of the principal terms an conditions and extent and operation of the charge

Rate of Interest:

LC: Commission as per bank norms.

CC (stock in trade) (Sub Limit to LC): IVRR-2.75%.

 

Terms of Repayment:

LC: On demand.

CC (stock in trade) (Sub Limit to LC): On demand.

 

Margin:

LC: Cash Margin 25%

CC (stock in trade) (Sub Limit to LC): 25% on stocks and book debts.

 

Extent and Operation of the charge:

First charge on stock in trade of the company both present and future.

First charge on book debts of the company both present and future.

Short particulars of the property charged

All the stock in trade of the company both present and future at Kanara Business Centre, B301,Near Everest Gardens Link Road, Laxmi Nagar, Ghatkopar (East), Mumbai-400075.

Entire book debts of the company both present and future.

 

TRADE REFERENCES:

 

v      Sterling Bio Pharma

v      Hydro Drags

v      RPG Lifesciences

 

FIXED ASSETS:

 

v      Air Condition

v      Computer

 


CMT REPORT (Corruption, Money Laundering & Terrorism]

 

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]         INFORMATION ON DESIGNATED PARTY

No records exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]         Court Declaration :

No records exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]         Asset Declaration :

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]         Record on Financial Crime :

            Charges or conviction registered against subject:                                                              None

 

5]         Records on Violation of Anti-Corruption Laws :

            Charges or investigation registered against subject:                                                          None

 

6]         Records on Int’l Anti-Money Laundering Laws/Standards :

            Charges or investigation registered against subject:                                                          None

 

7]         Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]         Affiliation with Government :

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]         Compensation Package :

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]        Press Report :

            No press reports / filings exists on the subject.

 


 

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

 

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.45.77

UK Pound

1

Rs.75.58

Euro

1

Rs.65.97

 


 

SCORE & RATING EXPLANATIONS

 

SCORE FACTORS

 

RANGE

POINTS

HISTORY

1~10

5

PAID-UP CAPITAL

1~10

3

OPERATING SCALE

1~10

3

FINANCIAL CONDITION

 

 

--BUSINESS SCALE

1~10

2

--PROFITABILIRY

1~10

2

--LIQUIDITY

1~10

3

--LEVERAGE

1~10

3

--RESERVES

1~10

2

--CREDIT LINES

1~10

3

--MARGINS

-5~5

--

DEMERIT POINTS

 

 

--BANK CHARGES

YES/NO

YES

--LITIGATION

YES/NO

NO

--OTHER ADVERSE INFORMATION

YES/NO

NO

MERIT POINTS

 

 

--SOLE DISTRIBUTORSHIP

YES/NO

NO

--EXPORT ACTIVITIES

YES/NO

NO

--AFFILIATION

YES/NO

NO

--LISTED

YES/NO

NO

--OTHER MERIT FACTORS

YES/NO

YES

TOTAL

 

26

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                 Payment record (10%)

Credit history (10%)                    Market trend (10%)                                Operational size (10%)

 


 

RATING EXPLANATIONS

 

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

-

NB

                                       New Business

-

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.